GSK Consumer: Bad news continues - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

GSK Consumer: Bad news continues

Apr 16, 2003

GlaxoSmithkline Consumer Healthcare Ltd. (SBCH) has posted a 38% dip in its 1QFY04 net profits. Though we do not have the company's detailed release on the results, as per the declared numbers, the company's gross sales has dipped by over 4% during the March quarter. The company has however, clarified that it has not lost market share in the malted beverage segment. With this, SBCH's poor showing continues.

(Rs m) 1QFY03 1QFY04 Change FY03 YoY Change
Net Sales 1,855 1,817 -2.0% 7,525 -9.9%
Other Income 41 39 -4.2% 146 -59.7%
Expenditure 1,395 1,467 5.2% 6,026 -8.3%
Operating Profit (EBDIT) 460 350 -23.9% 1,498 -16.0%
Operating Profit Margin (%) 24.8% 19.2%   19.9%  
Interest 3 2 -17.2% 24 -66.6%
Depreciation 34 91 168.7% 257 88.6%
Profit before Tax 463 295 -36.3% 1,364 -29.7%
Tax 169 99 -41.6% 453 -29.2%
Extraordinary items 0 -15 - -61 -
Profit after Tax/(Loss) 294 182 -38.3% 850 -34.6%
Net profit margin (%) 15.9% 10.0%   11.3%  
No. of Shares 45.4 45.4   45.4  
Diluted Earnings per share* 25.9 16.0   18.7  
P/E Ratio   14.4   12.3  

2002 was one of the worst years for the company wherein it reported a 9% dip in topline and nearly 35% dip in profits. Going by the March quarter results, 2003 has also started on a weak note. Though the topline dip is marginal and is a sign that the fall in revenues is getting arrested, it remains an area of concern. Operating margins for the company have dipped to 19.2%, almost a 5% fall in operating margins. This was mainly on account of higher advertising spending (10.5% of sales in 1QFY04 as compared to 9.0% last year).

A 14% hike in advertising revenues indicates the pressure on the company to maintain its growth. In 2002, the management had clarified that a lot of the de-growth in topline came as a consequence of an inventory correction. However, the pressure on topline continues. Being a single product focused company, this sort of degrowth in topline is very worrying, much like what has happened to Colgate. The stock has consequently, been hammered in the last one year.

Expenses as a % of sales 1QFY03 1QFY04
Stock -1.1% 2.9%
RM 33.3% 31.5%
Finished goods 0.6% 0.9%
Staff cost 10.4% 10.9%
Advt. 9.0% 10.5%
Other exps 21.7% 22.0%
Patent and trademark 0.7% 1.3%
Def. Rev. exps. 0.7% 0.7%
Total 75.2% 80.8%

At Rs 230, the stock trades at 14x annualised 1QFY04 earnings with market cap. to sales at 1.4x. Though the company's past growth track record is enthusing, we believe that it is moving towards a Colgate type fate unless it de-risks its product portfolio.

Equitymaster requests your view! Post a comment on "GSK Consumer: Bad news continues". Click here!


More Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Apr 15, 2020 (Close)


  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks